← back to search

Marcus Lefebure

Hypetex (United Kingdom) · GB
Area of research
Genetics · Pathology and Forensic Medicine
Research interest
Research interests include Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Acute Lymphoblastic Leukemia research, and Immunodeficiency and Autoimmune Disorders.
h-index
14
citations
1,144
works
35
NIH funding
primary concept
Medicine
email

Recent publications

The MURANO study: final analysis and retreatment/crossover substudy results of VenR for patients with relapsed/refractory CLL
Blood 2025cited by 37position: middledoi
Enduring undetectable MRD and updated outcomes in relapsed/refractory CLL after fixed-duration venetoclax-rituximab
Blood 2022cited by 147position: middledoi
Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen
Blood Advances 2022cited by 53position: middledoi
UNFAVORABLE GENETICS IMPACT MRD RESPONSE TO VENETOCLAX+RITUXIMAB RETREATMENT IN RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (R/R CLL): PHASE 3 MURANO SUBSTUDY
Hematological Oncology 2021cited by 3position: middledoi
Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study
Journal of Clinical Oncology 2020cited by 217position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Barbara Eichhorst · Okayama University Hospital3 papers (2021–2025)Yanwen Jiang · University College London3 papers (2021–2025)Clemens Mellink · Amsterdam UMC Location University of Amsterdam3 papers (2021–2025)Thomas J. Kipps · Moores Cancer Center3 papers (2021–2025)Carolyn Owen · Alberta Health Services3 papers (2021–2025)Arnon P. Kater · Amsterdam UMC Location Vrije Universiteit Amsterdam3 papers (2021–2025)Brenda Chyla · AbbVie (United States)3 papers (2021–2025)Michelle Boyer · Roche (United Kingdom)3 papers (2021–2025)John F. Seymour · Peter MacCallum Cancer Centre3 papers (2021–2025)Tadeusz Robak · Medical University of Lodz2 papers (2022–2025)Nicole Lamanna · NewYork–Presbyterian Hospital2 papers (2022–2025)Guillaume Cartron · Centre National de la Recherche Scientifique2 papers (2022–2025)Marco Montillo · Amsterdam University Medical Centers2 papers (2022–2025)Maria Thadani‐Mulero · Roche (United Kingdom)2 papers (2021–2025)Sarit Assouline · The Quebec Population Health Research Network2 papers (2022–2025)Javier de la Serna · Universidad Complutense de Madrid2 papers (2022–2025)Jane Wu · Merck & Co., Inc., Rahway, NJ, USA (United States)1 papers (2021–2021)Tong Lu · Jilin University1 papers (2022–2022)Jenny Wu · Duke University1 papers (2022–2022) · 1 papers (2021–2021)